In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), China Cord Blood Corp. (NYSE:CO) reported that Golden Meditech Holdings Ltd has picked up 78,874,106 of common stock as of 2017-04-13.
The acquisition brings the aggregate amount owned by Golden Meditech Holdings Ltd to a total of 78,874,106 representing a 65.40% stake in the company.
For those not familiar with the company, China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.
A glance at China Cord Blood Corp. (NYSE:CO)’s key stats reveals a current market capitalization of 591.58 Million based on 73.00 Million shares outstanding and a price at last close of $8.01 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-01-21, Mccarthy picked up 20,000 at a purchase price of $4.60. This brings their total holding to 10,648,946 as of the date of the filing.
On the sell side, the most recent transaction saw Mccarthy unload 5,000 shares at a sale price of $3.00. This brings their total holding to 7,901,724. It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on China Cord Blood Corp (NYSE:CO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.